|
|
Analysis on macular pigment optical density in diabetic patients without retinopathy |
XU Lijuan1,2, YU Rui1, LYU Zhigang1 |
1.Department of Ophthalmology, Jinhua Hospital, Zhejiang University, Jinhua, 321000; 2.Department of Ophthalmology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, 310016 |
|
Cite this article: |
XU Lijuan,YU Rui,LYU Zhigang. Analysis on macular pigment optical density in diabetic patients without retinopathy[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2017, 47(11): 820-823.
|
|
Abstract Objective: To compare macular pigment optical density (MPOD) between healthy Chinese people and type 2 diabetic patients without retinopathy using the one-wave length reflectometry and to evaluate the correlation of MPOD with serum lipid levels. Methods: Forty-one type 2 diabetes without retinopathy and 21 healthy controls were enrolled in this study. All subjects underwent blood tests which included glucose (GLU), glycated hemoglobin (HbA1c), cholesterol (CHOL), triglyceride (TG), low density lipoprotein (LDL), high density lipoprotein (HDL), creatinine (CR), blood urea nitrogen (BUN), retinol binding protein (RBP) and homocysteine (HCY). MPOD (including mean OD: mean macular pigment optical density and max OD: maximum macular pigment optical density) was measured with one-wavelength ophthalmoscope. Results: Mean OD of type 2 diabetes was lower than the normal controls [(0.15±0.03) du vs. (0.16±0.02) du, P<0.05]. Mean OD level was positively correlated with HDL (r=0.28, P<0.05). Conclusion: Mean OD in diabetic patients without retinopathy is lower than that of healthy controls, and MPOD may affected by HDL levels.
|
Received: 23 March 2017
|
|
|
|
|
[1] NISHIKAWA T, EDELSTEIN D, DU X L, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage[J]. Nature, 2000, 404 (6779): 787-790.
[2] GIACCO F, BROWNLEE M. Oxidative stress and diabetic complications[J]. Circ Res, 2010, 107(9): 1058-1070.
[3] MURIACH M, BOSCH-MORELL F, ALEXANDER G, et al. Lutein effect on retina and hippocampus of diabetic mice[J]. Free Radic Biol Med, 2006, 41(6): 979-984.
[4] SNODDERLY D M, BROWN P K, DELORI F C, et al. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate reti-nas[J]. Invest Ophthalmol Vis Sci, 1984, 25(6): 660-673.
[5] 葛坚, 赵家良, 黎晓新. 眼科学[J]. 2版. 北京: 人民卫生出版社, 2010: 305-306.
[6] SCHWEITZER D, JENTSCH S, DAWCZYNSKI J, et al. Simple and objective method for routine detection of the macular pigment xanthophyll[J]. J Biomed Opt, 2010, 15(6): 61714.
[7] BONE R A, LANDRUM J T, TARSIS S L. Preliminary identification of the human macular pigment[J]. Vision Res, 1985, 25(11): 1531-1535.
[8] LANDRUM J T, BONE R A, KILBURN M D. The macular pigment: a possible role in protection from age-related macular degeneration[J]. Adv Pharmacol,1997, 38: 537-556.
[9] SNODDERLY D M, BROWN P K, DELORI F C, et al. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas[J]. Invest Ophthalmol Vis Sci, 1984, 25(6): 660-673.
[10] VAN DER VEEN R L, BERENDSCHOT T T, MAKRIDAKI M, et al. Correspondence between retinal reflectometry and a flicker-based technique in the measurement of macular pigment spatial profiles[J]. J Biomed Opt, 2009, 14(6): 64046.
[11] BEATTY S, MURRAY I J, HENSON D B, et al. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population[J]. Invest Ophthalmol Vis Sci,2001, 42(2): 439-446.
[12] DELORI F C, GOGER D G, HAMMOND B R, et al. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic
flicker photometry[J]. J Opt Soc Am A Opt Image Sci Vis, 2001, 18(6): 1212-1230.
[13] MELLERIO J, AHMADI-LARI S, VAN KUIJK F, et al. A portable instrument for measuring macular pigment with central fixation[J]. Curr Eye Res, 2002, 25(1): 37-47.
[14] ZAGERS N P, POT M C, VAN NORREN D. Spectral and directional reflectance of the fovea in diabetes mellitus: photoreceptor integrity, macular pigment and lens[J]. Vision Res, 2005, 45(13): 1745-1753.
[15] 裴非, 陶玉婷. Web数据挖掘与图书馆信息个性化服务: 吉林省科技情报学会2010年学术年会[Z]. 长春: 20101-5.
[16] DAVIES N P, MORLAND A B. Color matching in diabetes: optical density of the crystalline lens and macular pigments [J]. Invest Ophthalmol Vis Sci,2002, 43(1): 281-289.
[17] LIMA V C, ROSEN R B, MAIA M, et al. Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study[J]. Invest Ophthalmol Vis Sci, 2010, 51(11): 5840-5845.
[18] FORD E S, WILL J C, BOWMAN B A, et al. Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey[J]. Am J Epidemiol,1999, 149(2): 168-176.
[19] PIPIS A, TOULIOU E, AUGUSTIN A J. Macular pigment optical density in a Central European population[J]. Ophthalmic Surg Lasers Imaging Retina, 2013, 44(3): 260-267.
[20] LIEW S H, GILBERT C E, SPECTOR T D, et al. Heritability of macular pigment: a twin study[J]. Invest Ophthalmol Vis Sci, 2005, 46(12): 4430-4436.
[21] HAMMOND C J, LIEW S H, VAN KUIJK F J, et al. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study[J]. Invest Ophthalmol Vis Sci, 2012, 53(8): 4963-4968.
[22] 聂景蓉, 戴桂祥, 谭章喜, 等. 血脂与糖尿病视网膜病变的相关性研究[J]. 山东医药, 2006, 46(7): 32-33.
[23] 董宁, 褚利群, 肖林, 等. 糖尿病患者黄斑色素密度的相关因素分析[J]. 实用医学杂志, 2012, 28(2): 243-245. |
|
|
|